QuEChERS Extraction and Simultaneous Quantification in GC-MS/MS of Hexahydrocannabinol Epimers and Their Metabolites in Whole Blood, Urine, and Oral Fluid
Recently, hexahydrocannabinol (HHC) was posed under strict control in Europe due to the increasing HHC-containing material seizures. The lack of analytical methods in clinical laboratories to detect HHC and its metabolites in biological matrices may result in related intoxication underreporting. We...
Saved in:
Published in | Molecules (Basel, Switzerland) Vol. 29; no. 14; p. 3440 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
22.07.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Recently, hexahydrocannabinol (HHC) was posed under strict control in Europe due to the increasing HHC-containing material seizures. The lack of analytical methods in clinical laboratories to detect HHC and its metabolites in biological matrices may result in related intoxication underreporting. We developed and validated a comprehensive GC-MS/MS method to quantify 9(R)-HHC, 9(S)-HHC, 9αOH-HHC, 9βOH-HHC, 8(R)OH-9(R)-HHC, 8(S)OH-9(S)HHC, 11OH-9(R)HHC, 11OH-9(S)HHC, 11nor-carboxy-9(R)-HHC, and 11nor-carboxy-9(S)-HHC in whole blood, urine, and oral fluid. A novel QuEChERS extraction protocol was optimized selecting the best extraction conditions suitable for all the three matrices. Urine and blood were incubated with β-glucuronidase at 60 °C for 2 h. QuEChERS extraction was developed assessing different ratios of Na2SO4:NaCl (4:1, 2:1, 1:1, w/w) to be added to 200 µL of any matrix added with acetonitrile. The chromatographic separation was achieved on a 7890B GC with an HP-5ms column, (30 m, 0.25 mm × 0.25 µm) in 12.50 min. The analytes were detected with a triple-quadrupole mass spectrometer in the MRM mode. The method was fully validated following OSAC guidelines. The method showed good validation parameters in all the matrices. The method was applied to ten real samples of whole blood (n = 4), urine (n = 3), and oral fluid (n = 3). 9(R)-HHC was the prevalent epimer in all the samples (9(R)/9(S) = 2.26). As reported, hydroxylated metabolites are proposed as urinary biomarkers, while carboxylated metabolites are hematic biomarkers. Furthermore, 8(R)OH-9(R)HHC was confirmed as the most abundant metabolite in all urine samples. |
---|---|
AbstractList | Recently, hexahydrocannabinol (HHC) was posed under strict control in Europe due to the increasing HHC-containing material seizures. The lack of analytical methods in clinical laboratories to detect HHC and its metabolites in biological matrices may result in related intoxication underreporting. We developed and validated a comprehensive GC-MS/MS method to quantify 9(R)-HHC, 9(S)-HHC, 9αOH-HHC, 9βOH-HHC, 8(R)OH-9(R)-HHC, 8(S)OH-9(S)HHC, 11OH-9(R)HHC, 11OH-9(S)HHC, 11nor-carboxy-9(R)-HHC, and 11nor-carboxy-9(S)-HHC in whole blood, urine, and oral fluid. A novel QuEChERS extraction protocol was optimized selecting the best extraction conditions suitable for all the three matrices. Urine and blood were incubated with β-glucuronidase at 60 °C for 2 h. QuEChERS extraction was developed assessing different ratios of Na2SO4:NaCl (4:1, 2:1, 1:1, w/w) to be added to 200 µL of any matrix added with acetonitrile. The chromatographic separation was achieved on a 7890B GC with an HP-5ms column, (30 m, 0.25 mm × 0.25 µm) in 12.50 min. The analytes were detected with a triple-quadrupole mass spectrometer in the MRM mode. The method was fully validated following OSAC guidelines. The method showed good validation parameters in all the matrices. The method was applied to ten real samples of whole blood (n = 4), urine (n = 3), and oral fluid (n = 3). 9(R)-HHC was the prevalent epimer in all the samples (9(R)/9(S) = 2.26). As reported, hydroxylated metabolites are proposed as urinary biomarkers, while carboxylated metabolites are hematic biomarkers. Furthermore, 8(R)OH-9(R)HHC was confirmed as the most abundant metabolite in all urine samples. Recently, hexahydrocannabinol (HHC) was posed under strict control in Europe due to the increasing HHC-containing material seizures. The lack of analytical methods in clinical laboratories to detect HHC and its metabolites in biological matrices may result in related intoxication underreporting. We developed and validated a comprehensive GC-MS/MS method to quantify 9(R)-HHC, 9(S)-HHC, 9αOH-HHC, 9βOH-HHC, 8(R)OH-9(R)-HHC, 8(S)OH-9(S)HHC, 11OH-9(R)HHC, 11OH-9(S)HHC, 11nor-carboxy-9(R)-HHC, and 11nor-carboxy-9(S)-HHC in whole blood, urine, and oral fluid. A novel QuEChERS extraction protocol was optimized selecting the best extraction conditions suitable for all the three matrices. Urine and blood were incubated with β-glucuronidase at 60 °C for 2 h. QuEChERS extraction was developed assessing different ratios of Na SO :NaCl (4:1, 2:1, 1:1, / ) to be added to 200 µL of any matrix added with acetonitrile. The chromatographic separation was achieved on a 7890B GC with an HP-5ms column, (30 m, 0.25 mm × 0.25 µm) in 12.50 min. The analytes were detected with a triple-quadrupole mass spectrometer in the MRM mode. The method was fully validated following OSAC guidelines. The method showed good validation parameters in all the matrices. The method was applied to ten real samples of whole blood (n = 4), urine (n = 3), and oral fluid (n = 3). 9(R)-HHC was the prevalent epimer in all the samples (9(R)/9(S) = 2.26). As reported, hydroxylated metabolites are proposed as urinary biomarkers, while carboxylated metabolites are hematic biomarkers. Furthermore, 8(R)OH-9(R)HHC was confirmed as the most abundant metabolite in all urine samples. Recently, hexahydrocannabinol (HHC) was posed under strict control in Europe due to the increasing HHC-containing material seizures. The lack of analytical methods in clinical laboratories to detect HHC and its metabolites in biological matrices may result in related intoxication underreporting. We developed and validated a comprehensive GC-MS/MS method to quantify 9(R)-HHC, 9(S)-HHC, 9αOH-HHC, 9βOH-HHC, 8(R)OH-9(R)-HHC, 8(S)OH-9(S)HHC, 11OH-9(R)HHC, 11OH-9(S)HHC, 11nor-carboxy-9(R)-HHC, and 11nor-carboxy-9(S)-HHC in whole blood, urine, and oral fluid. A novel QuEChERS extraction protocol was optimized selecting the best extraction conditions suitable for all the three matrices. Urine and blood were incubated with β-glucuronidase at 60 °C for 2 h. QuEChERS extraction was developed assessing different ratios of Na2SO4:NaCl (4:1, 2:1, 1:1, w/w) to be added to 200 µL of any matrix added with acetonitrile. The chromatographic separation was achieved on a 7890B GC with an HP-5ms column, (30 m, 0.25 mm × 0.25 µm) in 12.50 min. The analytes were detected with a triple-quadrupole mass spectrometer in the MRM mode. The method was fully validated following OSAC guidelines. The method showed good validation parameters in all the matrices. The method was applied to ten real samples of whole blood (n = 4), urine (n = 3), and oral fluid (n = 3). 9(R)-HHC was the prevalent epimer in all the samples (9(R)/9(S) = 2.26). As reported, hydroxylated metabolites are proposed as urinary biomarkers, while carboxylated metabolites are hematic biomarkers. Furthermore, 8(R)OH-9(R)HHC was confirmed as the most abundant metabolite in all urine samples.Recently, hexahydrocannabinol (HHC) was posed under strict control in Europe due to the increasing HHC-containing material seizures. The lack of analytical methods in clinical laboratories to detect HHC and its metabolites in biological matrices may result in related intoxication underreporting. We developed and validated a comprehensive GC-MS/MS method to quantify 9(R)-HHC, 9(S)-HHC, 9αOH-HHC, 9βOH-HHC, 8(R)OH-9(R)-HHC, 8(S)OH-9(S)HHC, 11OH-9(R)HHC, 11OH-9(S)HHC, 11nor-carboxy-9(R)-HHC, and 11nor-carboxy-9(S)-HHC in whole blood, urine, and oral fluid. A novel QuEChERS extraction protocol was optimized selecting the best extraction conditions suitable for all the three matrices. Urine and blood were incubated with β-glucuronidase at 60 °C for 2 h. QuEChERS extraction was developed assessing different ratios of Na2SO4:NaCl (4:1, 2:1, 1:1, w/w) to be added to 200 µL of any matrix added with acetonitrile. The chromatographic separation was achieved on a 7890B GC with an HP-5ms column, (30 m, 0.25 mm × 0.25 µm) in 12.50 min. The analytes were detected with a triple-quadrupole mass spectrometer in the MRM mode. The method was fully validated following OSAC guidelines. The method showed good validation parameters in all the matrices. The method was applied to ten real samples of whole blood (n = 4), urine (n = 3), and oral fluid (n = 3). 9(R)-HHC was the prevalent epimer in all the samples (9(R)/9(S) = 2.26). As reported, hydroxylated metabolites are proposed as urinary biomarkers, while carboxylated metabolites are hematic biomarkers. Furthermore, 8(R)OH-9(R)HHC was confirmed as the most abundant metabolite in all urine samples. |
Author | Pichini, Simona Tini, Anastasio Taoussi, Omayema Sprega, Giorgia Carlier, Jeremy Di Trana, Annagiulia Montanari, Eva Lo Faro, Alfredo Fabrizio Kobidze, Giorgi Bambagiotti, Giulia Fede, Maria Sofia Di Giorgi, Alessandro Busardò, Francesco Paolo |
Author_xml | – sequence: 1 givenname: Annagiulia surname: Di Trana fullname: Di Trana, Annagiulia – sequence: 2 givenname: Giorgia surname: Sprega fullname: Sprega, Giorgia – sequence: 3 givenname: Giorgi surname: Kobidze fullname: Kobidze, Giorgi – sequence: 4 givenname: Omayema orcidid: 0009-0008-0633-2117 surname: Taoussi fullname: Taoussi, Omayema – sequence: 5 givenname: Alfredo Fabrizio orcidid: 0000-0002-0240-5277 surname: Lo Faro fullname: Lo Faro, Alfredo Fabrizio – sequence: 6 givenname: Giulia surname: Bambagiotti fullname: Bambagiotti, Giulia – sequence: 7 givenname: Eva orcidid: 0000-0003-0044-1714 surname: Montanari fullname: Montanari, Eva – sequence: 8 givenname: Maria Sofia surname: Fede fullname: Fede, Maria Sofia – sequence: 9 givenname: Jeremy orcidid: 0000-0003-3332-9518 surname: Carlier fullname: Carlier, Jeremy – sequence: 10 givenname: Anastasio surname: Tini fullname: Tini, Anastasio – sequence: 11 givenname: Francesco Paolo surname: Busardò fullname: Busardò, Francesco Paolo – sequence: 12 givenname: Alessandro orcidid: 0000-0003-2997-221X surname: Di Giorgi fullname: Di Giorgi, Alessandro – sequence: 13 givenname: Simona surname: Pichini fullname: Pichini, Simona |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39065018$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ksluFDEQhlsoiCzwAFyQJS4cMsRuu7cjjCaLlFEUJhFHy0uZ8chtD3a3lLwKT4unJ0EoiJNL9vf_VeWq4-LABw9F8Z7gz5R2-KwPDtToIJUdYZQx_Ko4IqzEM4pZd_BXfFgcp7TBuCSMVG-KwyyuK0zao-LX7biYrxffVmjxMEShBhs8El6jle1HNwgPYUzodhR-sMYqMb1bjy7ms-XqbLlCwaBLeBDrRx2DEt4LaX1waLG1PcQ0Wd2twUa0hEHI4OwAaWfwfZ2LR19dCPoU3Ufr4XSCb6Jw6NyNVr8tXhvhErx7Ok-K-_PF3fxydn1zcTX_cj1TjLbDrMaCCSGF1syQWopS0dyZajtDcru0kkySHDcGdKuaGqTBBrq2BKmhqpuanhRXe18dxIZvo-1FfORBWD5dhPiDizhY5YC3sqo7JRpjGsw0NrLTdc4FSkLZ0LrJXp_2XtsYfo6QBt7bpMC5_Udyitsql0XJLu3HF-gmjNHnTncU61rcdTRTH56oUfag_5T3PMEMNHtAxZBSBMOVHaYx5XFaxwnmu13h_-xKVpIXymfz_2t-AxGVxQQ |
CitedBy_id | crossref_primary_10_33003_fjs_2024_0806_2957 crossref_primary_10_1038_s41598_025_93931_4 |
Cites_doi | 10.1007/978-1-0716-2605-4_7 10.1002/dta.3403 10.1002/dta.3595 10.1002/jms.4436 10.1007/s00216-013-7419-7 10.1007/s00769-002-0487-6 10.1007/s11419-021-00600-y 10.1002/dta.3038 10.1016/j.jpba.2023.115918 10.1021/ac020361s 10.2174/1570159X21666230623104624 10.1111/jnu.12817 10.1093/jat/bkad079 10.3390/ph17020249 10.1177/14690667231200139 10.1080/17425255.2023.2252324 10.1016/j.jpba.2022.114987 10.1021/acschemneuro.9b00586 10.1002/dta.3610 10.3389/fchem.2019.00109 |
ContentType | Journal Article |
Copyright | 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | AAYXX CITATION NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 DOA |
DOI | 10.3390/molecules29143440 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic DOAJ - Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef PubMed MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1420-3049 |
ExternalDocumentID | oai_doaj_org_article_8b569ca7ff704d0fb9d618cecbe27367 39065018 10_3390_molecules29143440 |
Genre | Journal Article |
GeographicLocations | United States--US |
GeographicLocations_xml | – name: United States--US |
GroupedDBID | --- 0R~ 123 2WC 53G 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ A8Z AADQD AAFWJ AAHBH AAYXX ABDBF ABUWG ACGFO ACIWK ACPRK ACUHS AEGXH AENEX AFKRA AFPKN AFRAH AFZYC AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS BENPR BPHCQ BVXVI CCPQU CITATION CS3 D1I DIK DU5 E3Z EBD EMOBN ESX FYUFA GROUPED_DOAJ GX1 HH5 HMCUK HYE HZ~ I09 IAO IHR ITC KQ8 LK8 M1P MODMG O-U O9- OK1 P2P PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RPM SV3 TR2 TUS UKHRP ~8M NPM 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 PUEGO |
ID | FETCH-LOGICAL-c438t-60a4aabadd4f16ba2c3018c89f121435b4b19f17fed8c76ebf0fe982ebde56763 |
IEDL.DBID | 7X7 |
ISSN | 1420-3049 |
IngestDate | Wed Aug 27 01:28:48 EDT 2025 Thu Jul 10 16:45:13 EDT 2025 Sat Jul 26 02:59:43 EDT 2025 Thu Apr 03 07:04:17 EDT 2025 Tue Jul 01 03:59:56 EDT 2025 Thu Apr 24 22:53:55 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 14 |
Keywords | cannabinoids hexahydrocannabinol epimers GC-MS/MS new psychoactive substances QuEChERS hexahydrocannabinol metabolites |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c438t-60a4aabadd4f16ba2c3018c89f121435b4b19f17fed8c76ebf0fe982ebde56763 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-0240-5277 0009-0008-0633-2117 0000-0003-3332-9518 0000-0003-2997-221X 0000-0003-0044-1714 |
OpenAccessLink | https://www.proquest.com/docview/3084980993?pq-origsite=%requestingapplication% |
PMID | 39065018 |
PQID | 3084980993 |
PQPubID | 2032355 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_8b569ca7ff704d0fb9d618cecbe27367 proquest_miscellaneous_3085121316 proquest_journals_3084980993 pubmed_primary_39065018 crossref_citationtrail_10_3390_molecules29143440 crossref_primary_10_3390_molecules29143440 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-Jul-22 |
PublicationDateYYYYMMDD | 2024-07-22 |
PublicationDate_xml | – month: 07 year: 2024 text: 2024-Jul-22 day: 22 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | Molecules (Basel, Switzerland) |
PublicationTitleAlternate | Molecules |
PublicationYear | 2024 |
Publisher | MDPI AG |
Publisher_xml | – name: MDPI AG |
References | Derne (ref_13) 2023; 16 Peters (ref_18) 2023; 19 (ref_7) 2023; 5 ref_14 Elskens (ref_23) 2002; 7 Schirmer (ref_10) 2023; 29 ref_12 ref_21 ref_20 Pulver (ref_3) 2023; 15 Haschimi (ref_4) 2021; 13 ref_1 ref_19 ref_15 Ifa (ref_17) 2019; 54 ref_9 Worob (ref_2) 2019; 11 Matuszewski (ref_24) 2003; 75 Meyer (ref_22) 2013; 405 Graziano (ref_8) 2023; 21 Manier (ref_11) 2023; 47 Suriaga (ref_5) 2023; 55 ref_6 Caldas (ref_16) 2022; 40 |
References_xml | – ident: ref_19 doi: 10.1007/978-1-0716-2605-4_7 – ident: ref_9 – volume: 15 start-page: 255 year: 2023 ident: ref_3 article-title: EMCDDA Framework and Practical Guidance for Naming Synthetic Cannabinoids publication-title: Drug Test. Anal. doi: 10.1002/dta.3403 – volume: 16 start-page: 638 year: 2023 ident: ref_13 article-title: Immunological Detection of Hexahydrocannabinol (HHC) in Oral Fluid publication-title: Drug Test. Anal. doi: 10.1002/dta.3595 – volume: 54 start-page: 834 year: 2019 ident: ref_17 article-title: Analysis of Tetrahydrocannabinol Derivative from Cannabis-Infused Chocolate by QuEChERS-Thin Layer Chromatography-Desorption Electrospray Ionization Mass Spectrometry publication-title: J. Mass Spectrom. doi: 10.1002/jms.4436 – volume: 405 start-page: 9779 year: 2013 ident: ref_22 article-title: Qualitative Metabolism Assessment and Toxicological Detection of Xylazine, a Veterinary Tranquilizer and Drug of Abuse, in Rat and Human Urine Using GC-MS, LC-MS n, and LC-HR-MS n publication-title: Anal. Bioanal. Chem. doi: 10.1007/s00216-013-7419-7 – volume: 7 start-page: 281 year: 2002 ident: ref_23 article-title: Linearity of Calibration Curves: Use and Misuse of the Correlation Coefficient publication-title: Accredit. Qual. Assur. doi: 10.1007/s00769-002-0487-6 – volume: 40 start-page: 88 year: 2022 ident: ref_16 article-title: Determination of New Psychoactive Substances and Other Drugs in Postmortem Blood and Urine by UHPLC–MS/MS: Method Validation and Analysis of Forensic Samples publication-title: Forensic. Toxicol. doi: 10.1007/s11419-021-00600-y – volume: 13 start-page: 1499 year: 2021 ident: ref_4 article-title: New Synthetic Cannabinoids Carrying a Cyclobutyl Methyl Side Chain: Human Phase I Metabolism and Data on Human Cannabinoid Receptor 1 Binding and Activation of Cumyl-CBMICA and Cumyl-CBMINACA publication-title: Drug Test. Anal. doi: 10.1002/dta.3038 – volume: 5 start-page: 165 year: 2023 ident: ref_7 article-title: Hexahydrocannabinol: Review of the Chemistry and Pharmacology of an Understudied Cannabinoid publication-title: Med. Cannabis Cannabinoids – ident: ref_12 doi: 10.1016/j.jpba.2023.115918 – volume: 75 start-page: 3019 year: 2003 ident: ref_24 article-title: Strategies for the Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on HPLC-MS/MS publication-title: Anal. Chem. doi: 10.1021/ac020361s – volume: 21 start-page: 2424 year: 2023 ident: ref_8 article-title: Hexahydrocannabinol Pharmacology, Toxicology, and Analysis: The First Evidence for a Recent New Psychoactive Substance publication-title: Curr. Neuropharmacol. doi: 10.2174/1570159X21666230623104624 – volume: 55 start-page: 623 year: 2023 ident: ref_5 article-title: Cannabinoids and Synthetic Cannabinoids as a Cause of Death: Trends and Their Healthcare Implications publication-title: J. Nurs. Scholarsh. doi: 10.1111/jnu.12817 – ident: ref_1 – volume: 47 start-page: 818 year: 2023 ident: ref_11 article-title: Analytical Toxicology of the Semi-Synthetic Cannabinoid Hexahydrocannabinol Studied in Human Samples, Pooled Human Liver S9 Fraction, Rat Samples and Drug Products Using HPLC-HRMS-MS publication-title: J. Anal. Toxicol. doi: 10.1093/jat/bkad079 – ident: ref_21 doi: 10.3390/ph17020249 – volume: 29 start-page: 326 year: 2023 ident: ref_10 article-title: Identification of Human Hexahydrocannabinol Metabolites in Urine publication-title: Eur. J. Mass Spectrom. doi: 10.1177/14690667231200139 – volume: 19 start-page: 487 year: 2023 ident: ref_18 article-title: Current State-of-the-Art Approaches for Mass Spectrometry in Clinical Toxicology: An Overview publication-title: Expert Opin. Drug Metab. Toxicol. doi: 10.1080/17425255.2023.2252324 – ident: ref_6 doi: 10.1016/j.jpba.2022.114987 – ident: ref_20 – volume: 11 start-page: 3881 year: 2019 ident: ref_2 article-title: DARK Classics in Chemical Neuroscience: Synthetic Cannabinoids (Spice/K2) publication-title: ACS Chem. Neurosci. doi: 10.1021/acschemneuro.9b00586 – ident: ref_15 doi: 10.1002/dta.3610 – ident: ref_14 doi: 10.3389/fchem.2019.00109 |
SSID | ssj0021415 |
Score | 2.4301164 |
Snippet | Recently, hexahydrocannabinol (HHC) was posed under strict control in Europe due to the increasing HHC-containing material seizures. The lack of analytical... |
SourceID | doaj proquest pubmed crossref |
SourceType | Open Website Aggregation Database Index Database Enrichment Source |
StartPage | 3440 |
SubjectTerms | cannabinoids Chromatography GC-MS/MS hexahydrocannabinol epimers hexahydrocannabinol metabolites Laboratories Marijuana Metabolism Metabolites Methods new psychoactive substances Psychotropic drugs QuEChERS Tetrahydrocannabinol THC Urine |
SummonAdditionalLinks | – databaseName: DOAJ - Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9swEBejL9vL2Pe8dUODPY2ayLYsS49rcBYG2ejSsL4ZfdJA6pTEge5f6V_bO8sJhbHtZW_GPotDd9LdSXe_I-SjsUyFSrJUYQoNh6AjNWCmUi89iBsMmu_R9mffxHTBv16UF_dafWFOWIQHjhM3kqYUyuoqhIpxx4JRTmTSems8WF7R15GDzdsHU0OolYFdineYBQT1o6vYatZvcwX-AceTjntWqAfr_7OH2VuayRPyeHAR6efI2lPywLfPyMPxvjPbc3J7tqvHl_WPOa1vuk2sTKC6dXS-xPxA3XoI5-nZTsdEoH7u6bKlX8bpbD6azek60Km_0Ze_HJgv3bYawuP1itbXSzzF7oc6xwsEOvMdKAmWKW9xgJ_YTJeeYq77CV1g3eBJT_x9A_xOVrule0EWk_p8PE2HHgup5YXsUsE019rALsdDJozOLax4aaUKWY6ulOEmg-cqeCdtJbwJLHglc2-cLwVsTi_JUbtu_WtCS2mNLhwIXwcuXKkKZVhgiEBouA0uIWw_540dAMixD8aqgUAExdT8JqaEfDr8ch3RN_5GfIqCPBAicHb_AtSpGdSp-Zc6JeR4rwbNsJq3TcEkVxJ86SIhHw6fQeh4uRKFijQlwuNlIiGvovocOAF2BQInvvkfHL4lj3JwrPB8Oc-PyVG32fl34Bh15n2_Bu4Aa1oOxQ priority: 102 providerName: Directory of Open Access Journals |
Title | QuEChERS Extraction and Simultaneous Quantification in GC-MS/MS of Hexahydrocannabinol Epimers and Their Metabolites in Whole Blood, Urine, and Oral Fluid |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39065018 https://www.proquest.com/docview/3084980993 https://www.proquest.com/docview/3085121316 https://doaj.org/article/8b569ca7ff704d0fb9d618cecbe27367 |
Volume | 29 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9NAEF5Be4AL4o2hRIvECdXKxl6v1ydEIqcRUgptGpGbtU8aKdghcaTyV_i1zNhOioToJbLi8Wrtmd157jeEvNeGZT6VLMywhIaD0xFqUFOhkw7YDQrNNWj703MxmfPPi2TRBdy2XVnlfk9sNmpbGYyR92MmeSbBnok_rn-G2DUKs6tdC4375Bihy7CkK13cOlwD0E5tJjMG177_o20467ZRBlYCx3jHX7qogez_v53Z6JvxY_KoMxTpp5azT8g9Vz4lD0b7_mzPyO-LXT66zi9nNL-pN-35BKpKS2dLrBJUpQOnnl7sVFsO1HCALkt6Ngqns_50RitPJ-5GXf-yoMRUWSpwkqsVzddLjGU3Q11hGoFOXQ2igoeVtzjAN2ypS4dY8X5K53h68LQh_rKB-Y5Xu6V9Tubj_Go0CbtOC6HhsaxDwRRXSsNex_1AaBUZWPfSyMwPIjSoNNcDuE69s9KkwmnPvMtk5LR1iYAt6gU5KqvSvSI0kUar2IIIKM-FTbI408wzxCHU3HgbELb_5oXpYMixG8aqAHcE2VT8w6aAfDg8sm4xOO4iHiIjD4QIn938UW2-F91qLKRORGZU6n3KuGVeZ1bA-zqjHZhzIg3IyV4Mim5Nb4tbCQzIu8NtYDqmWFqmIk2CIHkDEZCXrfgcZgLTFQif-Pruwd-QhxEYThg_jqITclRvdu4tGD617jXSDb9yfNYjx8P8_Otlrwki_AHBCQjZ |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VcigXxJuUAosEF1Qrjr1e7x4QoiFpSpuikkTtzeyTRkrtkIdo_wo_gt_IjB0HJERvvUXxZrTO983OzO7sDCGvtQmlT0UYSEyhYRB0BBrMVOCEA7jBoLmy2n7_mPdG7NNZcrZBftV3YTCtsl4Ty4XaFgb3yJtxKJgU4M_E76ffA-wahaerdQuNihaH7uoHhGzzdwcfAd83UdTtDNu9YNVVIDAsFouAh4oppUGvmW9xrSIDHBdGSN-K0HnQTLfgc-qdFSblTvvQOykip61LOKgjyL1FbrM4lqhRoru_DvBaYA2rk1N4GDYvqga3bh5JEMxwf-Uv21e2CPi_X1vat-49cnflmNIPFZPukw2XPyBb7bof3EPy82TZaZ93vgxo53Ixq-5DUJVbOhhjVqLKXbGc05OlqtKPSsTpOKf77aA_aPYHtPC05y7V-ZUFo6nyXEFQXkxoZzrGvfNS1BCPLWjfLYCaeDl6jgJOsYUv3cMM-106wtuKu-XgzzOYb3eyHNtHZHQjGDwmm3mRu6eEJsJoFVugnPKM20TGUoc-xLqHmhlvGySs__PMrMqeY_eNSQbhD8KU_QNTg7xd_2Ra1fy4bvAeArkeiOW6yy-K2bdspf2Z0AmXRqXepyGzodfScnhfZ7QD95GnDbJT0yBbrSHz7A_jG-TV-jGAjkc6Fag4JsGifC3eIE8q-qxnAtPlWK5x-3rhL8lWb9g_yo4Ojg-fkTsROG24dx1FO2RzMVu65-B0LfSLkumUfL1p1foN3PRD6g |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxELZKkaAXxJtAASPBBXUV78trHxCiaUJKSaGkEbktttduI4XdkIdo_wo_hV_HzD5SJERvvUUb78jJ941nxh7PEPJSGyZdIpgnMYUmgqDD02CmPCsswA0GzZbV9geHvD-KPozj8Qb53dyFwbTKZk0sF-qsMLhH3g6ZiKQAfyZsuzot4vNe7-3sh4cdpPCktWmnUVHkwJ7_hPBt8WZ_D7B-FQS97nGn79UdBjwThWLpcaYipTToeOR8rlVggO_CCOn8AB0JHWkfPifOZsIk3GrHnJUisDqzMQfVBLnXyPUkjH3UsWR8Eez5YBmrU9QwlKz9vWp2axeBBMER7rX8ZQfLdgH_93FLW9e7TW7VTip9V7HqDtmw-V1ys9P0hrtHfh2tup3T7pch7Z4t59XdCKryjA4nmKGoclusFvRopapUpBJ9Osnp-443GLYHQ1o42rdn6vQ8AwOq8lxBgF5MaXc2wX30UtQxHmHQgV0CTfGi9AIFfMV2vnQXs-136AhvLu6Ugz_NYb696WqS3SejK8HgAdnMi9w-IjQWRqswA_opF_EslqHUzDGsgagj47IWYc1_npq6BDp24pimEAohTOk_MLXI6_Urs6r-x2WDdxHI9UAs3V0-KOYnab0SpELHXBqVOJewKGNOy4zD77VGW3AledIi2w0N0no9WaQX7G-RF-uvAXQ83qlAxTExFujzeYs8rOiznglMl2PpxseXC39OboBSpR_3Dw-ekK0A_Dfcxg6CbbK5nK_sU_C_lvpZSXRKvl21Zv0BdKJIFw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=QuEChERS+Extraction+and+Simultaneous+Quantification+in+GC-MS%2FMS+of+Hexahydrocannabinol+Epimers+and+Their+Metabolites+in+Whole+Blood%2C+Urine%2C+and+Oral+Fluid&rft.jtitle=Molecules+%28Basel%2C+Switzerland%29&rft.au=Annagiulia+Di+Trana&rft.au=Sprega%2C+Giorgia&rft.au=Giorgi+Kobidze&rft.au=Taoussi%2C+Omayema&rft.date=2024-07-22&rft.pub=MDPI+AG&rft.eissn=1420-3049&rft.volume=29&rft.issue=14&rft.spage=3440&rft_id=info:doi/10.3390%2Fmolecules29143440&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-3049&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-3049&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-3049&client=summon |